Format
Sort by
Items per page

Send to

Choose Destination

Best matches for liver cancer AND epidemiology:

Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. Marengo A et al. Annu Rev Med. (2016)

[Current epidemiology and pathogenesis of non-alcoholic fatty liver disease-associated liver cancer]. Chen DF et al. Zhonghua Gan Zang Bing Za Zhi. (2017)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Massarweh NN et al. Cancer Control. (2017)

Search results

Items: 1 to 20 of 33016

1.

MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.

Torshizi Esfahani A, Seyedna SY, Nazemalhosseini Mojarad E, Majd A, Asadzadeh Aghdaei H.

J Cell Physiol. 2018 Dec 13. doi: 10.1002/jcp.27983. [Epub ahead of print]

PMID:
30549036
2.

HER2+ mCRC patients with exon 20 R784G substitution mutation do not respond to the cetuximab therapy.

Gharib E, Salmanipour R, Nazemalhosseini Mojarad E, Yaghoob Taleghani M, Sarlak S, Malekzade-Moghani M, Nasrabadi PN, Meiary MA, Asadzadeh Aghdaei H, Zali MR.

J Cell Physiol. 2018 Dec 13. doi: 10.1002/jcp.27984. [Epub ahead of print]

PMID:
30549033
3.

External validation of the PREDICT tool in Spanish women with breast cancer participating in population-based screening programmes.

Aguirre U, García-Gutiérrez S, Romero A, Domingo L, Castells X, Sala M; CAMISS Study Group.

J Eval Clin Pract. 2018 Dec 12. doi: 10.1111/jep.13084. [Epub ahead of print]

PMID:
30548721
4.

Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis.

Bastard JP, Fellahi S, Audureau É, Layese R, Roudot-Thoraval F, Cagnot C, Mahuas-Bourcier V, Sutton A, Ziol M, Capeau J, Nahon P.

Eur Cytokine Netw. 2018 Sep 1;29(3):112-120. doi: 10.1684/ecn.2018.0413.

PMID:
30547888
5.

Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma.

Cheng S, Li T, Wang C, Wang K, Lai C, Yan J, Fan H, Sun F, Wang Z, Zhang P, Yu L, Hong Z, Lei G, Sun B, Gao Y, Xiao Z, Ji X, Wang R, Wu J, Wang X, Zhang S, Yang P.

Oncotarget. 2017 Dec 8;9(90):36057-36066. doi: 10.18632/oncotarget.23282. eCollection 2018 Nov 16.

PMID:
30546827
6.

Racial disparities in the survival time of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma between Chinese patients and patients of other racial groups: A population-based study from 2004 to 2013.

Ren F, Zhang J, Gao Z, Zhu H, Chen X, Liu W, Xue Z, Gao W, Wu R, Lv Y, Hu L.

Oncol Lett. 2018 Dec;16(6):7102-7116. doi: 10.3892/ol.2018.9550. Epub 2018 Oct 5.

PMID:
30546445
7.

Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset.

Chen JS, Hung CY, Chang H, Liu CT, Chen YY, Lu CH, Chang PH, Hung YS, Chou WC.

Cancers (Basel). 2018 Dec 10;10(12). pii: E501. doi: 10.3390/cancers10120501.

PMID:
30544670
8.

Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States.

Han SS, Kelly SP, Li Y, Yang B, Nguyen M, So S, Rosenberg PS, Hsing AW.

J Natl Cancer Inst. 2018 Dec 13. doi: 10.1093/jnci/djy180. [Epub ahead of print]

PMID:
30544184
9.

Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.

Buron A, Román M, Augé JM, Macià F, Grau J, Sala M, Louro J, Martinez-Alonso M, Alvarez-Urturi C, Andreu M, Bessa X, Zaffalon D, Castells A, Pellisé M, Aldea M, Rivero L, Hernández C, Torá-Rocamora I, Castells X.

Eur J Cancer. 2018 Dec 10;107:53-59. doi: 10.1016/j.ejca.2018.11.004. [Epub ahead of print]

PMID:
30544059
10.

The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.

Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, Jin L, Zhang T, Chen X.

J Hepatol. 2018 Dec 10. pii: S0168-8278(18)32616-3. doi: 10.1016/j.jhep.2018.12.001. [Epub ahead of print]

PMID:
30543829
11.

Bayesian adjustment for trend of colorectal cancer incidence in misclassified registering across Iranian provinces.

Shojaee S, Hajizadeh N, Najafimehr H, Busani L, Pourhoseingholi MA, Baghestani AR, Nasserinejad M, Ashtari S, Zali MR.

PLoS One. 2018 Dec 13;13(12):e0199273. doi: 10.1371/journal.pone.0199273. eCollection 2018.

PMID:
30543626
12.

Evaluation of neck circumference as an easy and reliable predictor for non-alcoholic fatty liver disease.

Salmanroghani H, Salmanroghani R, Nourian M, Khayarn K, Lahmi F, Iravani S.

Turk J Gastroenterol. 2018 Dec 12. doi: 10.5152/tjg.2018.18004. [Epub ahead of print]

PMID:
30541716
13.

Ganodermanontriol inhibits expression of special AT rich sequence binding protein 1 gene in human hepatocellular carcinoma.

Xu C, Guo H, Kong D, Pang D, Ding Y.

J Cancer Res Ther. 2018 Dec;14(Supplement):S964-S968. doi: 10.4103/0973-1482.203597.

PMID:
30539830
14.

Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer.

Deng J, Ren Z, Wen J, Wang B, Hou X, Xue Z, Chu X.

Cancer Manag Res. 2018 Nov 22;10:6143-6156. doi: 10.2147/CMAR.S183878. eCollection 2018.

15.

Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.

Zhao HY, Gong Y, Ye FG, Ling H, Hu X.

Cancer Manag Res. 2018 Nov 20;10:5937-5950. doi: 10.2147/CMAR.S178395. eCollection 2018.

PMID:
30538544
Free Article
16.

Exosomes as a novel cell-free therapeutic approach in gastrointestinal diseases.

Baghaei K, Tokhanbigli S, Asadzadeh H, Nmaki S, Reza Zali M, Hashemi SM.

J Cell Physiol. 2018 Dec 7. doi: 10.1002/jcp.27934. [Epub ahead of print] Review.

PMID:
30536895
17.

miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features.

Gu Y, Wei X, Sun Y, Gao H, Zheng X, Wong LL, Jin L, Liu N, Hernandez BY, Peplowska K, Zhao X, Zhan QM, Feng XH, Tang ZY, Ji J.

Cancer Res. 2018 Dec 7. pii: canres.1675.2018. doi: 10.1158/0008-5472.CAN-18-1675. [Epub ahead of print]

PMID:
30530815
18.

Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.

Javed MA, Beyer G, Le N, Vinci A, Wong H, Palmer D, Morgan RD, Lamarca A, Hubner RA, Valle JW, Alam S, Chowdhury S, Ma YT, Archibugi L, Capurso G, Maisonneuve P, Neesse A, Sund M, Schober M, Krug S.

Pancreatology. 2018 Oct 15. pii: S1424-3903(18)30697-5. doi: 10.1016/j.pan.2018.10.003. [Epub ahead of print]

PMID:
30529068
19.

Renal cell carcinoma and brain metastasis: Questioning the dogma of role for cytoreductive nephrectomy.

Daugherty M, Daugherty E, Jacob J, Shapiro O, Mollapour M, Bratslavsky G.

Urol Oncol. 2018 Dec 5. pii: S1078-1439(18)30405-8. doi: 10.1016/j.urolonc.2018.10.021. [Epub ahead of print]

PMID:
30528396
20.

Hepatitis C incidence 3 years after implementation of an educate, test, and treat programme in an Egyptian village.

Shiha G, Soliman R, Mikhail NNH, Easterbrook P.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):13-14. doi: 10.1016/S2468-1253(18)30336-4. Epub 2018 Dec 6. No abstract available.

PMID:
30527578

Supplemental Content

Loading ...
Support Center